These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8628745

  • 21. Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light.
    Hei DJ, Grass J, Lin L, Corash L, Cimino G.
    Transfusion; 1999 Mar; 39(3):239-48. PubMed ID: 10204585
    [Abstract] [Full Text] [Related]

  • 22. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers.
    Margolis-Nunno H, Williams B, Rywkin S, Geacintov N, Horowitz B.
    Transfusion; 1992 Mar; 32(6):541-7. PubMed ID: 1502707
    [Abstract] [Full Text] [Related]

  • 23. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods.
    Dodd RY, Moroff G, Wagner S, Dabay MH, Dorfman E, George V, Ribeiro A, Shumaker J, Benade LE.
    Transfusion; 1991 Mar; 31(6):483-90. PubMed ID: 1853439
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dark and photoreactivity of 4'-aminomethyl-4,5',8-trimethylpsoralen with T7 phage.
    Tóth K, Csik G, Rontó G.
    J Photochem Photobiol B; 1990 Apr 15; 5(2):167-78. PubMed ID: 2111396
    [Abstract] [Full Text] [Related]

  • 27. Complete Inactivation of Blood Borne Pathogen Trypanosoma cruzi in Stored Human Platelet Concentrates and Plasma Treated With 405 nm Violet-Blue Light.
    Jankowska KI, Nagarkatti R, Acharyya N, Dahiya N, Stewart CF, Macpherson RW, Wilson MP, Anderson JG, MacGregor SJ, Maclean M, Dey N, Debrabant A, Atreya CD.
    Front Med (Lausanne); 2020 Apr 15; 7():617373. PubMed ID: 33330577
    [Abstract] [Full Text] [Related]

  • 28. Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease.
    de Almeida Nogueira NP, Morgado-Díaz JA, Menna-Barreto RF, Paes MC, da Silva-López RE.
    Acta Trop; 2013 Oct 15; 128(1):27-35. PubMed ID: 23770204
    [Abstract] [Full Text] [Related]

  • 29. Relaxation of supercoiled DNA by aminomethyl trimethylpsoralen and UV photons: action spectrum.
    Oroskar AA, Gasparro FP, Peak MJ.
    Photochem Photobiol; 1993 Apr 15; 57(4):648-54. PubMed ID: 8506393
    [Abstract] [Full Text] [Related]

  • 30. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
    Jauvin V, Alfonso RD, Guillemain B, Dupuis K, Fleury HJ.
    Transfusion; 2005 Jul 15; 45(7):1151-9. PubMed ID: 15987361
    [Abstract] [Full Text] [Related]

  • 31. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors.
    Cancino-Faure B, Fisa R, Riera C, Bula I, Girona-Llobera E, Jimenez-Marco T.
    Transfusion; 2015 Jun 15; 55(6):1249-55. PubMed ID: 25683267
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The Photoaddition of a Psoralen to DNA Proceeds via the Triplet State.
    Diekmann J, Gontcharov J, Fröbel S, Torres Ziegenbein C, Zinth W, Gilch P.
    J Am Chem Soc; 2019 Aug 28; 141(34):13643-13653. PubMed ID: 31415157
    [Abstract] [Full Text] [Related]

  • 34. The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood.
    Jimenez-Marco T, Cancino-Faure B, Girona-Llobera E, Alcover MM, Riera C, Fisa R.
    Transfusion; 2017 Jun 28; 57(6):1440-1447. PubMed ID: 28419477
    [Abstract] [Full Text] [Related]

  • 35. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.
    Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA.
    Transfusion; 2012 Feb 28; 52(2):409-16. PubMed ID: 21827502
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Binding affinities of commonly employed sensitizers of viral inactivation.
    Dardare N, Platz MS.
    Photochem Photobiol; 2002 Jun 28; 75(6):561-4. PubMed ID: 12081315
    [Abstract] [Full Text] [Related]

  • 38. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Högman CF.
    Vox Sang; 2000 Jun 28; 78(4):209-16. PubMed ID: 10895093
    [Abstract] [Full Text] [Related]

  • 39. The application of photosensitisers to tropical pathogens in the blood supply.
    Wainwright M, Baptista MS.
    Photodiagnosis Photodyn Ther; 2011 Sep 28; 8(3):240-8. PubMed ID: 21864797
    [Abstract] [Full Text] [Related]

  • 40. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.
    Umekita LF, Piazza RM, Mota I.
    Braz J Med Biol Res; 1994 Oct 28; 27(10):2391-9. PubMed ID: 7640629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.